Skip to main content
EUDA logo

EUDA · EUDA Health Holdings Ltd

$20.35 +0.45 (+2.26%) At close · Jul 29
Market Cap
$60.93M
Shares
2.99M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$6.82M +70%
FY2025 Revenue FY2022–FY2025
Net Income
-$2.77M +81.9%
FY2025 Net Income FY2022–FY2025
Gross Margin
43.88% +24.9pp
FY2025 Gross Margin FY2022–FY2025
Operating Margin
-36.33% +395.9pp
FY2025 Operating Margin FY2022–FY2025
Diluted EPS
-$1.48 +84.3%
FY2025 Diluted EPS FY2023–FY2025
Operating Cash Flow
-$2.43M -19.3%
FY2025 Operating Cash Flow FY2022–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022
$6.82M $4.01M $3.71M $9.84M
$3.83M $3.25M $2.86M $6.49M
$2.99M $762.16K $842.08K $3.35M
43.88% 19% 22.72% 34.08%
$249 $17.21K
$1.28M $129.87K $533.56K $1.9M
$4.15M $3.21M $4.27M $7.15M
$156.66K $20.17K $115.91K $115.91K
$195.21K $173.22K
$5.47M $18.1M $4.8M $15.41M
-$2.48M -$17.34M -$3.96M -$12.06M
-36.33% -432.19% -106.87% -122.53%
-$2.28M -$17.16M
$228.62K
-$247.78K -$307.03K -$4.47M -$12.87M
-$2.73M -$17.64M -$8.43M -$24.93M
$41.94K -$4379 -$20.79K $17.42K
-$2.77M -$15.36M -$10.04M -$24.88M
-40.65% -382.88% -270.86% -252.87%
$5052 -$34.29K $3377 -$65.12K
-$17.6M -$8.44M -$24.88M
-$2.72M -$15.43M -$10.1M -$25.02M
USD/shares -$1.48 -$9.40 -$8.80 -$41.40
USD/shares -$1.48 -$9.40 -$8.80
shares 1.87M 1.62M 1.15M 601.48K
shares 1.87M 1.62M 1.15M 601.48K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2022 FY2021
Medical Services $6,076,414 $5,986,030
Property Management Services $3,764,295 $4,558,520

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022
Singapore $4,827,569 $3,921,982 $3,706,458 $3,764,295
Malaysia $1,992,695 $89,023

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021
Property Management Services $4,367,584 $3,921,982 $3,764,295 $4,558,520
Property Management Service Common Area Management $3,252,982 $2,870,912 $2,628,073 $2,919,335 $3,508,663
Holistic Wellness Consumer Products and Services $2,452,680 $89,023
Wellness Therapies Service $1,772,614 $75,572
Property Management Service Security Management $1,114,602 $1,051,070 $1,078,385 $844,960 $1,049,857
Holistic Wellness Consumer Products $406,592 $3,262
Stem Cell Treatment Service $217,007
Licensing Service of Bio Energy Cabin $53,347 $7,299
Wellness Membership Program $3,120 $2,890
Medical Services General Practice $63,794 $712,712
Medical Services General Practice Related Parties $135 $4,640
Medical Services $6,065,233 $5,723,549
Medical Services Related Parties $135 $4,640
Medical Services Specialty Care $6,001,439 $5,010,837
Medical Services Sub Total $6,065,368 $5,728,189
Product Sales $11,046 $257,841
Property Management Service $3,764,295 $4,558,520

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component FY2022 FY2021
Medical Services -$2,463,593 -$1,186,885
Property Management Services -$2,991,371 -$41,342
Consolidated -$5,454,964 -$1,228,227

Operating Margin by Segment (%)

Component FY2022 FY2021
Medical Services -40.5% -19.8%
Property Management Services -79.5% -0.9%
Key facts CIK 1847846 CUSIP G3142E147 Visit website Investor relations